79347413 - M MENARINI MENARINI STEMLINE ONCOLOGY

Information

• Trademark
• 79347413

• Source

• Serial Number

  79347413

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 13, 2022
  2 years ago

• Transaction Date

  January 25, 2025
  17 days ago

• Status Date

  January 02, 2024
  a year ago

• Location Date

  January 02, 2024
  a year ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  STEINPFAD, SARAH

• Attorney Name

  Arthur J. DeBaugh

  Law Office Assigned Location Code

  N20

• Owners

  • A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L

Case File Statements

• DM0000: The mark consists of an upper-case letter "M" outlined in black, the interior of the letter is white, the two right triangles formed by the bottom of the "M" are of the color red, and the large isosceles triangle formed at the top of the letter "M" is black and is bisected from the bottom to top by the name "MENARINI" in upper-case lettering in white. On the right side of the letter "M" is the name "MENARINI" in black in upper-case lettering and the name "STEMLINE" in black in lower-case lettering, with the upper-case letter "S". Beneath the letter "M" and the names "MENARINI" and "STEMLINE" is a black horizontal line, which is interrupted in the center by the name "ONCOLOGY" in black in Italic lettering. The color red is in the two right triangles formed by the bottom of the letter "M"; the color white is in the interior of the letter "M" and in the name "MENARINI" that is inside the isosceles triangle formed at the top of the letter "M"; the color black is in the isosceles triangle
• GS0051: Diagnostic reagents for medical use; pharmaceutical preparations and substances for the treatment of cancer
• CC0000: The color(s) red, black and white is/are claimed as a feature of the mark.
• GS0421: Biomedical research services; pharmaceutical products development; design and testing of new products; testing of pharmaceuticals; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fields

Case File Event Statements

• 8/24/2022 - 2 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/12/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC

• 8/22/2022 - 2 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 8/30/2022 - 2 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 10/25/2022 - 2 years ago

  5 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 3/15/2023 - a year ago

  6 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 3/15/2023 - a year ago

  7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 3/15/2023 - a year ago

  8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/15/2023 - a year ago

  9 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 3/15/2023 - a year ago

  10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/15/2023 - a year ago

  11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 4/28/2023 - a year ago

  12 - ASSIGNED TO EXAMINER Type: DOCK

• 5/5/2023 - a year ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/6/2023 - a year ago

  14 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 7/10/2023 - a year ago

  17 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/15/2023 - a year ago

  15 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/15/2023 - a year ago

  16 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/17/2024 - a year ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/17/2024 - a year ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 1/2/2024 - a year ago

  18 - ASSIGNED TO EXAMINER Type: DOCK

• 1/2/2024 - a year ago

  19 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 1/2/2024 - a year ago

  20 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 1/2/2024 - a year ago

  21 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 3/17/2024 - 11 months ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 1/3/2025 - a month ago

  25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 1/3/2025 - a month ago

  26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 1/25/2025 - 17 days ago

  27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT